Company Filing History:
9 out of 2,361 
9 out of 10 
4 out of 3,701 
Years Active: 2016-2023
Title: The Innovative Contributions of Theodore Michael Tarasow
Introduction
Theodore Michael Tarasow is a notable inventor based in San Ramon, California. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 12 patents to his name, Tarasow's work focuses on advancing therapeutic methods for glioblastoma and other cancers.
Latest Patents
One of his latest patents is titled "Procaspase combination therapy for glioblastoma." This invention provides compositions and methods for the induction of cell death, specifically targeting cancer cells. The patent discloses combinations of compounds and related methods of use, including their application in cancer therapy and the selective induction of apoptosis in cells. Notably, the disclosed drug combinations can exhibit lower neurotoxicity effects compared to other compounds and combinations. Another significant patent is "Procaspase 3 activation by combination therapy," which similarly focuses on the induction of cancer cell death through innovative compositions and methods.
Career Highlights
Throughout his career, Tarasow has worked with esteemed institutions, including the University of Illinois and Vanquish Oncology, Inc. His experience in these organizations has contributed to his expertise in cancer research and therapeutic development.
Collaborations
Some of his notable coworkers include Paul Joseph Hergenrother and Rachel C. Botham. Their collaborative efforts have likely enhanced the impact of Tarasow's inventions in the field of oncology.
Conclusion
Theodore Michael Tarasow's innovative work in cancer treatment exemplifies the importance of research and development in medical science. His patents reflect a commitment to improving therapeutic options for patients facing challenging diagnoses.